世界のパレコキシブナトリウム市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Parecoxib Sodium (CAS 198470-85-8) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-105X13292
• 出版社/出版日： / 2021年5月
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、パレコキシブナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。パレコキシブナトリウムの種類別市場規模（一般医薬品、ジェネリック医薬品）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・パレコキシブナトリウムの市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Sailong Pharma、Chiarai Tianqing、Qilu Pharma、Kelun Pharma
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：一般医薬品、ジェネリック医薬品
・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局
・パレコキシブナトリウムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・パレコキシブナトリウムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・パレコキシブナトリウムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・パレコキシブナトリウムの南米市場規模2016年-2026年：ブラジル、アルゼンチン
・パレコキシブナトリウムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Parecoxib Sodium (CAS 198470-85-8) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Parecoxib Sodium (CAS 198470-85-8) size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Parecoxib Sodium (CAS 198470-85-8) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Parecoxib Sodium (CAS 198470-85-8) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Original Drug
Generic Drug

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global Parecoxib Sodium (CAS 198470-85-8) market are listed below:
Pfizer
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Parecoxib Sodium (CAS 198470-85-8) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Parecoxib Sodium (CAS 198470-85-8) Market Size & Forecast
1.4.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Value (2016-2026))
1.4.2 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Volume (2016-2026)
1.4.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2016-2026) & (USD/Kg)
1.5 Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity Analysis
1.5.1 Global Parecoxib Sodium (CAS 198470-85-8) Total Production Capacity (2016-2026)
1.5.2 Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parecoxib Sodium (CAS 198470-85-8) Market Drivers
1.6.2 Parecoxib Sodium (CAS 198470-85-8) Market Restraints
1.6.3 Parecoxib Sodium (CAS 198470-85-8) Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Parecoxib Sodium (CAS 198470-85-8) Product and Services
2.1.4 Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sailong Pharma
2.2.1 Sailong Pharma Details
2.2.2 Sailong Pharma Major Business
2.2.3 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
2.2.4 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Chiarai Tianqing
2.3.1 Chiarai Tianqing Details
2.3.2 Chiarai Tianqing Major Business
2.3.3 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Product and Services
2.3.4 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Qilu Pharma
2.4.1 Qilu Pharma Details
2.4.2 Qilu Pharma Major Business
2.4.3 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
2.4.4 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Kelun Pharma
2.5.1 Kelun Pharma Details
2.5.2 Kelun Pharma Major Business
2.5.3 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
2.5.4 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Parecoxib Sodium (CAS 198470-85-8) Sales by Manufacturer
3.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Parecoxib Sodium (CAS 198470-85-8)
3.4 Market Concentration Rate
3.4.1 Top 3 Parecoxib Sodium (CAS 198470-85-8) Manufacturer Market Share
3.4.2 Top 6 Parecoxib Sodium (CAS 198470-85-8) Manufacturer Market Share
3.5 Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Parecoxib Sodium (CAS 198470-85-8) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parecoxib Sodium (CAS 198470-85-8) Market Size by Region
4.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Region (2016-2026)
4.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2016-2026)
4.2 North America Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026)
4.3 Europe Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026)
4.4 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026)
4.5 South America Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026)
4.6 Middle East and Africa Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Type (2016-2026)
5.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type (2016-2026)
5.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Application (2016-2026)
6.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application (2016-2026)
6.3 Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2026)
7.2 North America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2026)
7.3 North America Parecoxib Sodium (CAS 198470-85-8) Market Size by Country
7.3.1 North America Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Country (2016-2026)
7.3.2 North America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2026)
8.2 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2026)
8.3 Europe Parecoxib Sodium (CAS 198470-85-8) Market Size by Country
8.3.1 Europe Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Country (2016-2026)
8.3.2 Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2026)
9.2 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2026)
9.3 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Market Size by Region
9.3.1 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2026)
10.2 South America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2026)
10.3 South America Parecoxib Sodium (CAS 198470-85-8) Market Size by Country
10.3.1 South America Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Country (2016-2026)
10.3.2 South America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2026)
11.2 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2026)
11.3 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Market Size by Country
11.3.1 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Parecoxib Sodium (CAS 198470-85-8) Typical Distributors
12.3 Parecoxib Sodium (CAS 198470-85-8) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Parecoxib Sodium (CAS 198470-85-8) Product and Services
Table 6. Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sailong Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Sailong Pharma Major Business
Table 9. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
Table 10. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Chiarai Tianqing Basic Information, Manufacturing Base and Competitors
Table 12. Chiarai Tianqing Major Business
Table 13. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Product and Services
Table 14. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Qilu Pharma Major Business
Table 17. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
Table 18. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Kelun Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Kelun Pharma Major Business
Table 21. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Product and Services
Table 22. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Manufacturer (2019-2021e) & (Kg)
Table 24. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Parecoxib Sodium (CAS 198470-85-8), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity by Company, (Kg): 2020 VS 2021
Table 27. Head Office and Parecoxib Sodium (CAS 198470-85-8) Production Site of Key Manufacturer
Table 28. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2016-2021e) & (Kg)
Table 29. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2021-2026) & (Kg)
Table 30. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 33. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 34. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2016-2021e) & (USD/Kg)
Table 37. Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2021-2026) & (USD/Kg)
Table 38. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 39. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 40. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2016-2021e) & (USD/Kg)
Table 43. Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2021-2026) & (USD/Kg)
Table 44. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2016-2021e) & (Kg)
Table 45. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2021-2026) & (Kg)
Table 46. North America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 49. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 50. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 51. North America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 52. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2016-2021e) & (Kg)
Table 53. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2021-2026) & (Kg)
Table 54. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 57. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 58. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 59. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 60. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2016-2021e) & (Kg)
Table 61. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2021-2026) & (Kg)
Table 62. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 65. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 66. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 67. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 68. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2016-2021e) & (Kg)
Table 69. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2021-2026) & (Kg)
Table 70. South America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 73. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 74. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 75. South America Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 76. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2016-2021e) & (Kg)
Table 77. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2021-2026) & (Kg)
Table 78. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2016-2021e) & (Kg)
Table 81. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2021-2026) & (Kg)
Table 82. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2016-2021e) & (Kg)
Table 83. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2021-2026) & (Kg)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Parecoxib Sodium (CAS 198470-85-8) Typical Distributors
Table 87. Parecoxib Sodium (CAS 198470-85-8) Typical Customers
List of Figures
Figure 1. Parecoxib Sodium (CAS 198470-85-8) Picture
Figure 2. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2020
Figure 3. Original Drug
Figure 4. Generic Drug
Figure 5. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Parecoxib Sodium (CAS 198470-85-8) Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 10. Global Parecoxib Sodium (CAS 198470-85-8) Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Parecoxib Sodium (CAS 198470-85-8) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Parecoxib Sodium (CAS 198470-85-8) Sales (2016-2026) & (Kg)
Figure 31. Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity (2016-2026) & (Kg)
Figure 32. Global Parecoxib Sodium (CAS 198470-85-8) Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Parecoxib Sodium (CAS 198470-85-8) Market Drivers
Figure 34. Parecoxib Sodium (CAS 198470-85-8) Market Restraints
Figure 35. Parecoxib Sodium (CAS 198470-85-8) Market Trends
Figure 36. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Manufacturer in 2020
Figure 37. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Manufacturer in 2020
Figure 38. Parecoxib Sodium (CAS 198470-85-8) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Parecoxib Sodium (CAS 198470-85-8) Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Parecoxib Sodium (CAS 198470-85-8) Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2016-2026)
Figure 42. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2016-2026)
Figure 43. North America Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026) & (USD Million)
Figure 44. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026) & (USD Million)
Figure 46. South America Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue (2016-2026) & (USD Million)
Figure 48. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2016-2026)
Figure 49. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Type (2016-2026)
Figure 50. Global Parecoxib Sodium (CAS 198470-85-8) Price by Type (2016-2026) & (USD/Kg)
Figure 51. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 52. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Application (2016-2026)
Figure 53. Global Parecoxib Sodium (CAS 198470-85-8) Price by Application (2016-2026) & (USD/Kg)
Figure 54. North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2016-2026)
Figure 55. North America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2016-2026)
Figure 56. North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2016-2026)
Figure 57. North America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 58. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2016-2026)
Figure 59. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2016-2026)
Figure 60. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2016-2026)
Figure 61. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 66. South America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2016-2026)
Figure 67. South America Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2016-2026)
Figure 68. South America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2016-2026)
Figure 69. South America Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

以下、関連資料のご紹介

世界のワルファリンナトリウム市場 2021：企業別、地域別、種類・用途別

Global Warfarin Sodium (CAS 129-06-6) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X15346 2021年5月 108Pages
当調査資料では、ワルファリンナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワルファリンナトリウムの種類別市場規模（1mg/錠、2.5mg/錠、5mg/錠）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ...

世界のブロムフェナクナトリウム市場 2021：企業別、地域別、種類・用途別

Global Bromfenac Sodium (CAS 91714-93-1) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X02915 2021年5月 100Pages
当調査資料では、ブロムフェナクナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ブロムフェナクナトリウムの種類別市場規模（オリジナル医薬品、ジェネリック医薬品）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリ...

世界のセフチゾキシムナトリウム市場 2021：企業別、地域別、種類・用途別

Global Ceftizoxime Sodium (CAS 68401-82-1) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X03470 2021年5月 130Pages
当調査資料では、セフチゾキシムナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セフチゾキシムナトリウムの種類別市場規模（0.5g/ベイル、1.0g/ベイル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ...

世界のシチコリンナトリウム市場 2021：企業別、地域別、種類・用途別

Global Citicoline Sodium (CAS 33818-15-4) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X03797 2021年5月 134Pages
当調査資料では、シチコリンナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。シチコリンナトリウムの種類別市場規模（注射、経口）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界のジクロフェナクナトリウム市場 2021：企業別、地域別、種類・用途別

Global Diclofenac Sodium Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X05168 2021年5月 108Pages
当調査資料では、ジクロフェナクナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ジクロフェナクナトリウムの種類別市場規模（タブレット、注射）、用途別市場規模（高齢者、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南ア...

世界のフマル酸ステアリルナトリウム市場 2021：企業別、地域別、種類・用途別

Global Sodium Stearyl Fumarate (CAS 4070-80-8) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X19206 2021年5月 108Pages
当調査資料では、フマル酸ステアリルナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フマル酸ステアリルナトリウムの種類別市場規模（純度≥98％、純度≥99％）、用途別市場規模（錠剤、カプセル、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...

世界のセフォペラゾンナトリウム市場 2021：企業別、地域別、種類・用途別

Global Cefoperazone Sodium Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X03467 2021年5月 108Pages
当調査資料では、セフォペラゾンナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。セフォペラゾンナトリウムの種類別市場規模（純度≥98％、純度≥99％）、用途別市場規模（セフォペラゾンナトリウム注射、その他）、地域別市場規模（北米、アメリカ、ヨー...

世界のメチルパラベンナトリウム市場 2021：企業別、地域別、種類・用途別

Global Sodium Methyl Paraben Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X19198 2021年5月 102Pages
当調査資料では、メチルパラベンナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メチルパラベンナトリウムの種類別市場規模（無色結晶、白色結晶性粉末）、用途別市場規模（製薬産業、食品産業、繊維産業、日常工業製品）、地域別市場規模（北米、アメリカ、...

世界のエポプロステノールナトリウムFDF市場 2021：企業別、地域別、種類・用途別

Global Epoprostenol Sodium FDF Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-105X06361 2021年5月 102Pages
当調査資料では、エポプロステノールナトリウムFDFのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エポプロステノールナトリウムFDFの種類別市場規模（0.5mg、1.5mg）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッ...

パレコキシブの世界市場2018-2025 In 2018, the global Parecoxib market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Parecoxib. This study researches the marke…
世界のブロムフェナクナトリウム市場 2021：企業別、地域別、種類・用途別 The Bromfenac Sodium (CAS 91714-93-1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
世界のワルファリンナトリウム市場 2021：企業別、地域別、種類・用途別 The Warfarin Sodium (CAS 129-06-6) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
プラバスタチンナトリウム薬の世界市場2018-2025 Fluvastatin is a member of the statin drug class, used to treat hypercholesterolemia and to prevent cardiovascular disease.In 2018, the global Fluvastatin Sodium Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has …
世界のセフチゾキシムナトリウム市場 2021：企業別、地域別、種類・用途別 The Ceftizoxime Sodium (CAS 68401-82-1) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…